CN117860838A - 一种伤科膏及其制备方法 - Google Patents
一种伤科膏及其制备方法 Download PDFInfo
- Publication number
- CN117860838A CN117860838A CN202311866611.XA CN202311866611A CN117860838A CN 117860838 A CN117860838 A CN 117860838A CN 202311866611 A CN202311866611 A CN 202311866611A CN 117860838 A CN117860838 A CN 117860838A
- Authority
- CN
- China
- Prior art keywords
- parts
- plaster
- traumatology
- root
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000011505 plaster Substances 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 20
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 13
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 13
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 13
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940116229 borneol Drugs 0.000 claims abstract description 13
- 229930008380 camphor Natural products 0.000 claims abstract description 13
- 229960000846 camphor Drugs 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 10
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 10
- 239000009136 dragon's blood Substances 0.000 claims abstract description 10
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 9
- 241001254604 Angelica pubescens Species 0.000 claims abstract description 9
- 235000005206 Hibiscus Nutrition 0.000 claims abstract description 9
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims abstract description 9
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 9
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims abstract description 9
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims abstract description 9
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 9
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 9
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 9
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 9
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 9
- 239000009910 sargent gloryvine Substances 0.000 claims abstract description 9
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 3
- 239000002994 raw material Substances 0.000 claims description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 6
- 239000009286 sanguis draxonis Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 229940041616 menthol Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- -1 vaseline Chemical compound 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 229940057995 liquid paraffin Drugs 0.000 claims description 3
- 229960001047 methyl salicylate Drugs 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- 229960001296 zinc oxide Drugs 0.000 claims description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 229940043266 rosin Drugs 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 2
- 230000036407 pain Effects 0.000 abstract description 52
- 208000002193 Pain Diseases 0.000 abstract description 51
- 230000008961 swelling Effects 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 241000411851 herbal medicine Species 0.000 abstract description 11
- 208000014674 injury Diseases 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 10
- 230000004054 inflammatory process Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 208000010392 Bone Fractures Diseases 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 4
- 230000008338 local blood flow Effects 0.000 abstract description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000002757 inflammatory effect Effects 0.000 abstract description 2
- 206010061623 Adverse drug reaction Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 26
- 206010042674 Swelling Diseases 0.000 description 21
- 230000017531 blood circulation Effects 0.000 description 10
- 230000003213 activating effect Effects 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 7
- 241000219061 Rheum Species 0.000 description 7
- 230000007803 itching Effects 0.000 description 7
- 241001106477 Paeoniaceae Species 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000002040 relaxant effect Effects 0.000 description 6
- 210000002435 tendon Anatomy 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010061363 Skeletal injury Diseases 0.000 description 5
- 210000001624 hip Anatomy 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000003131 sacroiliac joint Anatomy 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 201000011275 Epicondylitis Diseases 0.000 description 2
- 208000007353 Hip Osteoarthritis Diseases 0.000 description 2
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000026137 Soft tissue injury Diseases 0.000 description 2
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 208000036319 cervical spondylosis Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000018937 joint inflammation Diseases 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 208000005801 spondylosis Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010023204 Joint dislocation Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010061223 Ligament injury Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010072970 Meniscus injury Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000024288 Rotator Cuff injury Diseases 0.000 description 1
- 206010039227 Rotator cuff syndrome Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000002659 acromion Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009525 mild injury Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/289—Vladimiria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种伤科膏及其制备方法,涉及骨伤药物技术领域。该伤科膏,包括以下重量份组分:黄柏10‑20份、大黄5‑10份、赤芍5‑10份、白芷10‑20份、延胡索5‑10份、羌活10‑20份、独活10‑20份、大血藤10‑20份、芙蓉叶10‑20份、川木香10‑20份、血竭5‑10份、薄荷3‑5份、冰片3‑5份、樟脑3‑5份。本发明的伤科膏多种中草药组成,具有消炎止痛、化瘀止血、祛瘀生新等作用。它可以通过皮肤直接作用于患处,改善局部血液循环,促进炎症消退和损伤修复。此外,该伤科膏还可以抑制炎症介质的释放,缓解疼痛和肿胀等症状。与传统西医治疗方法相比,该伤科膏不会产生药物依赖性和副作用,可以促进局部血液循环和新陈代谢,还可以调节免疫功能,减轻患者的痛苦和焦虑等情绪症状。
Description
技术领域
本发明涉及骨伤药物技术领域,具体为一种伤科膏及其制备方法。
背景技术
中医骨伤科疾病是指骨骼系统因外力或内因导致的损伤和疾病。常见的中医骨伤科疾病包括骨折、关节脱位、颈椎病、腰椎间盘突出、软组织损伤等。这些疾病的产生原因可能包括跌打损伤、车祸、过度运动等。
中医骨伤科疾病的康复难易程度取决于多种因素。首先,骨伤科疾病的程度和复杂性不同,对于轻度损伤,如韧带扭伤、肌肉拉伤等,一般恢复较快;而对于严重的骨折、关节脱位等,恢复时间则较长,需要手术和长期的康复治疗。其次,患者的年龄、健康状况和基础疾病也会影响康复速度。一般来说,年轻患者身体状况较好,恢复较快;而老年患者身体机能下降,恢复较慢。同时,患有糖尿病、高血压等慢性疾病的患者,也会影响骨伤科疾病的康复。此外,治疗方法和护理措施也是影响康复的重要因素。正确的治疗方法可以减轻患者的痛苦,加速康复进程;而不当的治疗方法则可能加重病情,甚至导致后遗症。在护理方面,良好的护理可以预防感染、减轻疼痛、促进愈合,而护理不当则可能引发并发症,影响康复。
发明内容
(一)解决的技术问题
针对现有技术的不足,本发明提供了伤科膏及其制备方法,不仅对骨伤疾病能彻底根治,而且能全面调整人体各器官,特别是对神经、肌肉、筋膜疗效更佳。
(二)技术方案
为实现以上目的,本发明公开了一种新的治疗骨伤的药物,它是采用上等纯天然中草药的根、茎、叶花、果实、种子、菌类及昆虫与矿物质,经过清洗,烘干等工艺,在无菌、无尘的条件下,用中药粉碎机将中草药分别磨碎至10目,按配比掺和混均而成,该中药混合粉可做成浸膏剂、散剂、酒剂等,使用方便,循序止痛治痛,疗效稳定,治疗彻底,无任何毒副作用。伤科膏及其制备方法是用10余种中草药精制而成,主要用于治疗骨伤类,如:关节炎、颈椎病、腰椎间盘突出、软组织损伤等病,还可以用来治疗各种用于跌打损伤引起的红肿、疼痛。
本发明通过以下技术方案予以实现:一种伤科膏,包括以下重量份组分:黄柏10-20份、大黄5-10份、赤芍5-10份、白芷10-20份、延胡索5-10份、羌活10-20份、独活10-20份、大血藤10-20份、芙蓉叶10-20份、川木香10-20份、血竭5-10份、薄荷3-5份、冰片3-5份、樟脑3-5份。
优选的,包括以下重量份组分:黄柏11份、大黄5份、赤芍5份、白芷11份、延胡索5份、羌活11份、独活11份、大血藤11份、芙蓉叶11份、川木香11份、血竭6份、薄荷5份、冰片5份、樟脑5份。
本发明进一步公开了该伤科膏的制备方法,包括以下步骤:
步骤一:取料:
将黄柏、大黄、赤芍、白芷、延胡索、羌活、独活、大血藤、芙蓉叶、川木香、血竭,对其进行清洗并烘干,备用;
步骤二:粉碎:
将上述原料依次置于中药粉碎机中进行粉碎,并过目筛;
步骤三:熬制:
将上述原料:黄柏、大黄、赤芍、白芷、延胡索、羌活、独活、大血藤、芙蓉叶、川木香、血竭和水按配比依次置于熬制锅中进行熬制,并加入辅料,熬制1-2小时;
步骤四:制备:
在熬制中按配比依次加入薄荷脑、冰片、樟脑,直至熬制成橡胶状,即得到伤科膏。
优选的,步骤一中,所述清洗和烘干步骤在无菌、无尘环境下进行。
优选的,步骤二中,所述目筛的目数为10-20目。
优选的,步骤三中,所述熬制锅的温度为80-100℃。
优选的,步骤三中,所述辅料为水杨酸甲酯、橡胶、凡士林、氧化锌、液状石蜡、松香、羊毛脂,且按等量配比。
优选的,还包括对伤科膏进行涂布,得到伤科贴膏。
本发明所用主要中药原料的药理如下:
黄柏:具有清热解毒,燥湿止痒的作用,在伤科膏药中常用于减轻炎症,缓解疼痛和肿胀。
大黄:具有活血化瘀,消肿止痛的功效,对于跌打损伤,瘀血肿痛有很好的疗效。
赤芍:具有活血散瘀,清热凉血的作用,可用于改善血液循环,缓解疼痛,并防止感染。
白芷:具有祛风止痛,消肿排脓的效果。对于风湿痹痛,牙痛有很好的缓解作用。
延胡索:具有活血止痛,行气舒筋的功能。常用于治疗各种疼痛,特别是对于瘀血疼痛有特效。
羌活:具有散寒止痛,祛风除湿的作用。常用于治疗风湿痹痛,肩背酸痛。
独活:具有祛风除湿,通痹止痛的效果。常用于治疗风湿痹痛,腰膝酸痛。
大血藤:具有清热解毒,活血止痛的作用。常用于治疗风湿痹痛,痈肿疮毒。
芙蓉叶:具有清热解毒,消肿止痛的功能。常用于治疗痈疽疔疖,丹毒等。
川木香:具有行气止痛,舒筋活络的作用。常用于治疗关节疼痛,跌打损伤。
血竭:具有活血化瘀,消肿止痛的功效。可用于各种瘀血肿痛,外伤出血。
薄荷脑:具有消炎镇痛,清凉止痒的作用。可减轻皮肤炎症,并有助于缓解疼痛和瘙痒。
冰片:具有消炎镇痛,清凉止痒的作用。可减轻皮肤炎症,并有助于缓解疼痛和瘙痒。
樟脑:具有消炎镇痛,清凉止痒的作用。可减轻皮肤炎症,并有助于缓解疼痛和瘙痒。同时还有防腐作用,可防止膏药变质。
(三)有益效果
本发明提供了伤科膏及其制备方法。具备以下有益效果:
1、抗炎作用:伤科膏中的中草药成分具有很好的抗炎作用,能够有效地抑制炎症细胞的活化和炎症因子的释放,从而减轻炎症反应,缓解疼痛和肿胀等症状。
2、促进血液循环:伤科膏能够有效地促进血液循环,增加局部血液流量,从而改善局部代谢状况,有利于伤口的愈合和受损组织的恢复。
3、舒筋活络:伤科膏中的中草药成分具有舒筋活络的作用,能够缓解肌肉紧张和疼痛,改善局部血液循环,促进关节液的分泌和吸收,从而缓解关节疼痛和活动受限等症状。
附图说明
图1为本发明的制备方法流程示意图。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例一:
本发明实施例提供一种伤科膏,包括黄柏10份、大黄5份、赤芍5份、白芷10份、延胡索6份、羌活12份、独活12份、大血藤12份、芙蓉叶12份、川木香12份、血竭6份、薄荷3份、冰片3份、樟脑3份。
如图1所示,本发明还提供该伤科膏的制备方法,包括以下步骤:
步骤一:取原料:黄柏、大黄、赤芍、白芷、延胡索、羌活、独活、大血藤、芙蓉叶、川木香、血竭,在无菌无尘环境下,对其进行清洗,并烘干,备用;
步骤二:将上述原料依次置于中药粉碎机中进行粉碎,并过10目的目筛;
步骤三:将上述原料:黄柏、大黄、赤芍、白芷、延胡索、羌活、独活、大血藤、芙蓉叶、川木香、血竭和水按配比依次置于100℃的熬制锅中进行熬制,并等量配比加入水杨酸甲酯、橡胶、凡士林、氧化锌、液状石蜡、松香、羊毛脂,熬制2小时;
步骤四:在熬制中按配比依次加入薄荷脑、冰片、樟脑,直至熬制成橡胶状,即得到伤科膏。
实施例二:
本实施例与实施例一的不同之处在于:一种伤科膏,包括黄柏11份、大黄5、赤芍5份、白芷11份、延胡索5份、羌活11份、独活11份、大血藤11份、芙蓉叶11份、川木香11份、血竭6份、薄荷3份、冰片3份、樟脑3份。
实施例三:
本实施例与实施例一的不同之处在于:一种伤科膏,包括黄柏10份、大黄5、赤芍5份、白芷10份、延胡索5份、羌活10份、独活10份、大血藤10份、芙蓉叶10份、川木香10份、血竭5份、薄荷2份、冰片2份、樟脑2份。
实施例四:
本实施例与实施例一的不同之处在于:一种伤科膏,包括黄柏10份、大黄5份、赤芍5份、白芷10份、延胡索5份、羌活10份、独活10份、大血藤10份、芙蓉叶10份、川木香10份、血竭5份、薄荷3份、冰片3份、樟脑3份。
实施例五:
本实施例与实施例一的不同之处在于:一种伤科膏的制备方法,还包括对伤科膏进行涂布,得到伤科贴膏。
实施例六:
本实施例与实施例二的不同之处在于:一种伤科膏的制备方法,还包括对伤科膏进行涂布,得到伤科贴膏。
实施例七:
本实施例与实施例三的不同之处在于:一种伤科膏的制备方法,还包括对伤科膏进行涂布,得到伤科贴膏。
实验例:
案例一:李某,22岁,篮球大前锋运动员;主诉:右膝疼痛、肿胀、无法正常行走;核磁共振结果:前交叉韧带损伤,半月板撕裂。
使用实施例一的伤科膏后:2天疼痛明显减轻,肿胀逐渐消退,经过一周时间的康复训练后,现已重返赛场,运动表现良好。
案例二:张某,20岁,舞蹈演员;主诉:左踝疼痛、肿胀、无法正常活动;核磁共振示:左踝距腓前韧带损伤。
使用实施例二的伤科膏后:疼痛明显减轻,肿胀逐渐消退,经过康复训练后,已逐渐恢复到正常表演水平。
案例三:丁某某,25岁,200米田径运动员;主诉:腰部疼痛、肿胀、无法正常弯腰;核磁共振结果:L45腰椎间盘突出。
使用实施例三的伤科膏后:疼痛明显减轻,肿胀逐渐消退,经过物理治疗和神经松动训练,逐渐恢复竞技状态。
案例四:赵某,27岁,游泳运动员;主诉:左肩部疼痛、肿胀、无法正常上举;核磁共振:肩袖损伤、肩峰撞击综合征。
使用实施例四的伤科膏后:疼痛明显减轻,肿胀逐渐消退,经过电针治疗和康复训练,现已恢复到竞技水平。
案例五:刘某,22岁,滑雪运动员;主诉:右肘疼痛、肿胀、无法正常弯曲伸直;核磁共振结果:肱骨内上髁炎、肱骨外上髁炎。
使用实施例五的伤科贴膏后:疼痛减轻,肿胀逐渐消退,经过物理治疗和康复训练,已逐渐恢复到雪上训练。
案例六:马某,男,24岁,足球中后卫运动员,长期进行急加速、急停、铲球等高强度运动;主诉:右膝疼痛,休息、理疗后不见减轻;核磁共振示:右膝半月板损伤。
使用实施例六的伤科贴膏后:当日疼痛明显缓解,一周后疼痛消失,明显好转,现投入训练比赛中。
案例七:陈某,38岁,马拉松长跑运动员;主诉:背部和腰部交汇处(骶髂关节)疼痛、肿胀、无法正常走路或站立,感觉僵硬麻木,影响生活,腿部放射性疼痛;核磁共振示:骶髂关节炎症(强直性脊柱炎)和髋关节骨关节炎,骶髂关节有炎症和水肿;CT结果:骶髂关节炎症(强直性脊柱炎)和髋关节骨关节炎,骶髂关节有炎症和水肿。
使用实施例七的伤科贴膏后:可以下床行走并开始进行少量运动,腰部僵硬感消失且没有出现疼痛和麻木症状,腿部放射性疼痛得到缓解。该运动员每天仍然使用伤科贴膏并开始进行运动锻炼和瑜伽练习以增强身体柔韧性和肌肉力量。
同时,该伤科膏相比传统膏药的6大优势:1成分天然:配方采用天然的中草药为原料,不含有激素和副作用成分,不会对皮肤和身体产生刺激和过敏反应,更加安全可靠。2作用全面:具有抗炎、止痛、活血化瘀、舒筋活络等多重作用,能够针对各种跌打损伤、关节疼痛等症状进行综合治疗,效果更加明显。3使用方便:此膏为外用制剂,直接贴于患处即可,不需要经过口服或注射等繁琐的用药程序,使用更加方便快捷。4渗透性强:伤科膏及其制备方法中的中草药成分具有很好的渗透性,能够快速渗透到皮肤深层,作用于患处,从而缩短治疗时间,提高治疗效果。5副作用小:由于采用天然的中草药为原料,不含有激素和副作用成分,因此使用后不会对皮肤和身体产生依赖性和成瘾性,更加安全可靠。6价格实惠:相比传统膏药,该配方的价格更加实惠,更加适合广大普通百姓的需求。
综上所述,该伤科膏是一种安全有效、使用方便、价格实惠的中药外用制剂,具有抗炎、止痛、活血化瘀、舒筋活络等多重作用。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (8)
1.一种伤科膏,其特征在于:包括以下重量份组分:黄柏10-20份、大黄5-10份、赤芍5-10份、白芷10-20份、延胡索5-10份、羌活10-20份、独活10-20份、大血藤10-20份、芙蓉叶10-20份、川木香10-20份、血竭5-10份、薄荷3-5份、冰片3-5份、樟脑3-5份。
2.根据权利要求1所述的一种伤科膏,其特征在于:包括以下重量份组分:黄柏11份、大黄5份、赤芍5份、白芷11份、延胡索5份、羌活11份、独活11份、大血藤11份、芙蓉叶11份、川木香11份、血竭6份、薄荷5份、冰片5份、樟脑5份。
3.根据权利要求1-2所述的一种伤科膏的制备方法,其特征在于:包括以下步骤:
步骤一:取料:
将黄柏、大黄、赤芍、白芷、延胡索、羌活、独活、大血藤、芙蓉叶、川木香、血竭,对其进行清洗,并烘干,备用;
步骤二:粉碎:
将上述原料依次置于中药粉碎机中进行粉碎,并过目筛;
步骤三:熬制:
将上述原料:黄柏、大黄、赤芍、白芷、延胡索、羌活、独活、大血藤、芙蓉叶、川木香、血竭和水按配比依次置于熬制锅中进行熬制,并加入辅料,熬制1-2小时;
步骤四:制备:
在熬制中按配比依次加入薄荷脑、冰片、樟脑,直至熬制成橡胶状,即得到伤科膏。
4.根据权利要求3所述的一种伤科膏的制备方法,其特征在于:步骤一中,所述清洗和烘干步骤在无菌、无尘环境下进行。
5.根据权利要求3所述的一种伤科膏的制备方法,其特征在于:步骤二中,所述目筛的目数为10-20目。
6.根据权利要求3所述的一种伤科膏的制备方法,其特征在于:步骤三中,所述熬制锅的温度为80-100℃。
7.根据权利要求3所述的一种伤科膏的制备方法,其特征在于:步骤三中,所述辅料为水杨酸甲酯、橡胶、凡士林、氧化锌、液状石蜡、松香、羊毛脂,且按等量配比。
8.根据权利要求3所述的一种伤科膏的制备方法,其特征在于:还包括对伤科膏进行涂布,得到伤科贴膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311866611.XA CN117860838A (zh) | 2023-12-29 | 2023-12-29 | 一种伤科膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311866611.XA CN117860838A (zh) | 2023-12-29 | 2023-12-29 | 一种伤科膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117860838A true CN117860838A (zh) | 2024-04-12 |
Family
ID=90582365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311866611.XA Pending CN117860838A (zh) | 2023-12-29 | 2023-12-29 | 一种伤科膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117860838A (zh) |
-
2023
- 2023-12-29 CN CN202311866611.XA patent/CN117860838A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103156972B (zh) | 一种治疗骨折、骨裂和跌打损伤的中药组合物 | |
CN104771654A (zh) | 治疗腰椎、颈椎骨质增生的中药及其制备方法 | |
CN102309723B (zh) | 一种治疗关节疼痛的中药组合物及其药膏的制备方法 | |
CN103893380A (zh) | 一种治疗脊椎骨质增生中药制剂 | |
CN1733047A (zh) | 治疗跌打损伤的内用药 | |
CN1325110C (zh) | 跌打药酒 | |
CN102793888A (zh) | 一种治疗肩周炎的中药组合物 | |
CN101352506A (zh) | 一种治疗骨科疾病的药物及其制备方法和应用 | |
CN104083568A (zh) | 一种苗医骨痛膏药及其制备方法 | |
CN103585483B (zh) | 一种治疗膝骨性关节病的中药组合物及其制备方法 | |
CN117860838A (zh) | 一种伤科膏及其制备方法 | |
CN102370836B (zh) | 一种治疗创伤性滑膜炎的外敷中药 | |
CN107998235B (zh) | 治疗踝关节扭伤的复方壮药物及其制备方法 | |
CN111358915A (zh) | 一种治疗先天性肌性斜颈的中药及其制备方法 | |
CN110538272A (zh) | 一种治疗软组织损伤关节肿痛的消肿通络散及其制备方法 | |
CN101194985B (zh) | 一种内服用于治疗膝关节骨质增生的中药组合物 | |
CN104984310A (zh) | 一种治疗骨性关节炎的中药组合物及其制备方法 | |
CN104524080A (zh) | 主治跌打损伤中药剂及制备方法 | |
CN103585257A (zh) | 一种治疗骨折的中药散剂 | |
CN104173765B (zh) | 温热渗透治疗修复运动损伤的中药制剂和药包 | |
CN103083489B (zh) | 治腰椎病、颈椎病、骨质增生早期、陈年旧伤的中药酒剂 | |
CN115177690B (zh) | 一种用于治疗骨性关节炎的中药组合物及其制备方法 | |
CN112755134B (zh) | 一种用于治疗骨质增生的膏药及其制备方法 | |
CN102018858A (zh) | 一种治疗扭筋的中药组合物 | |
CN105902670A (zh) | 一种用于创伤性骨裂的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |